Gordon R. Greenberg - Concepedia

Author

Gordon R. Greenberg

Also Known As

G GREENBERG, G Greenberg, G R Greenberg, G. Greenberg, G. R. GREENBERG, G. R. Greenberg, G. Robert Greenberg, G.R Greenberg, G.R. Greenberg, G.Robert Greenberg

262

Publications

17K

Citations

H-Index

174

Concepts

All Affiliations

University of Toronto Mount Sinai Hospital University of Michigan Western University University of Alberta

About

Gordon R. Greenberg is an author at University of Toronto specializing in medicine, gastroenterology, and biochemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	41	79	7.8K
2	Engineering	13	13	728
3	Health Sciences	11	12	906
4	Arts	1	1	91
5	Education	1	1	47

Gordon R. Greenberg

161

Publications

16.5K

Citations

H-Index

Page 1

	Year	Citations
Ustekinumab Induction and Maintenance Therapy in Refractory Crohn's Disease William J. Sandborn, Christopher Gasink, Long-Long Gao, New England Journal of Medicine	2012	1.1K
Methotrexate for the Treatment of Crohn's Disease Brian G. Feagan, James Rochon, Richard N. Fedorak, New England Journal of Medicine	1995	913
Functional variants of OCTN cation transporter genes are associated with Crohn disease Vanya Peltekova, Richard F. Wintle, Laurence A. Rubin, Nature Genetics InflammationAutoimmune DiseaseMucosal ImmunologyGastrointestinal PharmacologyCrohn Disease	2004	839
Genetic variation in the 5q31 cytokine gene cluster confers susceptibility to Crohn disease John D. Rioux, Mark J. Daly, Mark S. Silverberg, Nature Genetics InflammationChronic Inflammatory DiseasesMucosal ImmunologyCrohn DiseasePathogenesis	2001	777
A Comparison of Methotrexate with Placebo for the Maintenance of Remission in Crohn's Disease Brian G. Feagan, Richard N. Fedorak, E. Jan Irvine, New England Journal of Medicine	2000	721
Treatment of Ulcerative Colitis with a Humanized Antibody to the α <sub>4</sub> β <sub>7</sub> Integrin Brian G. Feagan, Gordon R. Greenberg, Gary Wild, New England Journal of Medicine	2005	689
Association of Trough Serum Infliximab to Clinical Outcome After Scheduled Maintenance Treatment for Crohn’s Disease Elana Maser, Renata Villela, Mark S. Silverberg, Clinical Gastroenterology and Hepatology InflammationChronic Inflammatory DiseasesImmunologyGastroenterologyChronic Inflammation	2006	614
Oral Budesonide for Active Crohn's Disease Gordon R. Greenberg, Brian G. Feagan, François Martin, New England Journal of Medicine	1994	566
Genomewide Search in Canadian Families with Inflammatory Bowel Disease Reveals Two Novel Susceptibility Loci John D. Rioux, Mark S. Silverberg, Mark J. Daly, The American Journal of Human Genetics Genome-wide Association StudyNext-generation SequencingGeneticsGenetic EpidemiologyCanadian Families	2000	499
Early combined immunosuppression for the management of Crohn's disease (REACT): a cluster randomised controlled trial Reena Khanna, Brian Bressler, Barrett G. Levesque, The Lancet InflammationChronic Inflammatory DiseasesAutoimmune DiseaseMucosal ImmunologyImmunosuppressive Therapy	2015	452

Page 1